Gaining insights into chronic obstructive pulmonary disease exacerbation through emerging biomarkers and the chronic obstructive pulmonary disease assessment test score
Chronic obstructive pulmonary disease (COPD), a leading cause of mortality and morbidity, presents significant challenges, particularly with exacerbations, which drastically impact patients' health and healthcare costs. The Global Initiative for Chronic Obstructive Lung Disease guidelines reco...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
PAGEPress Publications
2024-03-01
|
Series: | Monaldi Archives for Chest Disease |
Subjects: | |
Online Access: | https://www.monaldi-archives.org/macd/article/view/2955 |
_version_ | 1797262015924797440 |
---|---|
author | Megha Hegde Saurav Raj Aishwarya S Pattanshetti Sanatkumar Bharamu Nyamagoud |
author_facet | Megha Hegde Saurav Raj Aishwarya S Pattanshetti Sanatkumar Bharamu Nyamagoud |
author_sort | Megha Hegde |
collection | DOAJ |
description |
Chronic obstructive pulmonary disease (COPD), a leading cause of mortality and morbidity, presents significant challenges, particularly with exacerbations, which drastically impact patients' health and healthcare costs. The Global Initiative for Chronic Obstructive Lung Disease guidelines recommend comprehensive assessments beyond spirometry, with the COPD assessment test (CAT) emerging as a pivotal tool. Despite its utility, the relationship between CAT scores and specific biomarkers during exacerbations remains unclear. Hence, this study aims to assess the correlation between the CAT score and specific circulating biomarkers. A cross-sectional study from August 2023 to January 2024 included 59 COPD patients with exacerbations who underwent pulmonary function tests and completed the CAT score assessment. The CAT score cut-off point was set at 20, where a CAT score <20 indicated a low impact on health status and a CAT score ≥20 indicated a high impact on health status. On the same day, measurements of neutrophils, leukocytes, eosinophils, C-reactive protein, and procalcitonin were conducted. Patients with CAT scores ≥20 had significantly higher levels of neutrophils (p=0.001), leukocytes (p=0.006), procalcitonin (p=0.010), and forced expiratory volume in the first second/forced vital capacity (p=0.002), but lower eosinophil levels (p=0.025). A positive correlation existed between total CAT score and neutrophils (p=0.001), leukocytes (p=0.000), and procalcitonin (p=0.010), while eosinophil levels showed a negative correlation (p=0.025). The spirometry parameters showed no correlation with the total CAT score. This study highlights the link between CAT and key inflammatory biomarkers, supporting the use of blood biomarkers to identify COPD patients at risk of exacerbations.
|
first_indexed | 2024-04-24T23:50:24Z |
format | Article |
id | doaj.art-fb1c21728dfb47cda80642e00052425e |
institution | Directory Open Access Journal |
issn | 1122-0643 2532-5264 |
language | English |
last_indexed | 2024-04-24T23:50:24Z |
publishDate | 2024-03-01 |
publisher | PAGEPress Publications |
record_format | Article |
series | Monaldi Archives for Chest Disease |
spelling | doaj.art-fb1c21728dfb47cda80642e00052425e2024-03-14T20:18:57ZengPAGEPress PublicationsMonaldi Archives for Chest Disease1122-06432532-52642024-03-0110.4081/monaldi.2024.2955Gaining insights into chronic obstructive pulmonary disease exacerbation through emerging biomarkers and the chronic obstructive pulmonary disease assessment test scoreMegha Hegde0Saurav Raj1Aishwarya S Pattanshetti2Sanatkumar Bharamu Nyamagoud3Department of Pharmacy Practice, KLE College of Pharmacy, Hubli, KarnatakaDepartment of Pharmacy Practice, KLE College of Pharmacy, Hubli, KarnatakaHCG - KLE Suchirayu Hospital, Hubballi, KarnatakaDepartment of Pharmacy Practice, KLE College of Pharmacy, Hubli, Karnataka Chronic obstructive pulmonary disease (COPD), a leading cause of mortality and morbidity, presents significant challenges, particularly with exacerbations, which drastically impact patients' health and healthcare costs. The Global Initiative for Chronic Obstructive Lung Disease guidelines recommend comprehensive assessments beyond spirometry, with the COPD assessment test (CAT) emerging as a pivotal tool. Despite its utility, the relationship between CAT scores and specific biomarkers during exacerbations remains unclear. Hence, this study aims to assess the correlation between the CAT score and specific circulating biomarkers. A cross-sectional study from August 2023 to January 2024 included 59 COPD patients with exacerbations who underwent pulmonary function tests and completed the CAT score assessment. The CAT score cut-off point was set at 20, where a CAT score <20 indicated a low impact on health status and a CAT score ≥20 indicated a high impact on health status. On the same day, measurements of neutrophils, leukocytes, eosinophils, C-reactive protein, and procalcitonin were conducted. Patients with CAT scores ≥20 had significantly higher levels of neutrophils (p=0.001), leukocytes (p=0.006), procalcitonin (p=0.010), and forced expiratory volume in the first second/forced vital capacity (p=0.002), but lower eosinophil levels (p=0.025). A positive correlation existed between total CAT score and neutrophils (p=0.001), leukocytes (p=0.000), and procalcitonin (p=0.010), while eosinophil levels showed a negative correlation (p=0.025). The spirometry parameters showed no correlation with the total CAT score. This study highlights the link between CAT and key inflammatory biomarkers, supporting the use of blood biomarkers to identify COPD patients at risk of exacerbations. https://www.monaldi-archives.org/macd/article/view/2955COPDexacerbationbiomarkersCOPD assessment testCATcorrelation |
spellingShingle | Megha Hegde Saurav Raj Aishwarya S Pattanshetti Sanatkumar Bharamu Nyamagoud Gaining insights into chronic obstructive pulmonary disease exacerbation through emerging biomarkers and the chronic obstructive pulmonary disease assessment test score Monaldi Archives for Chest Disease COPD exacerbation biomarkers COPD assessment test CAT correlation |
title | Gaining insights into chronic obstructive pulmonary disease exacerbation through emerging biomarkers and the chronic obstructive pulmonary disease assessment test score |
title_full | Gaining insights into chronic obstructive pulmonary disease exacerbation through emerging biomarkers and the chronic obstructive pulmonary disease assessment test score |
title_fullStr | Gaining insights into chronic obstructive pulmonary disease exacerbation through emerging biomarkers and the chronic obstructive pulmonary disease assessment test score |
title_full_unstemmed | Gaining insights into chronic obstructive pulmonary disease exacerbation through emerging biomarkers and the chronic obstructive pulmonary disease assessment test score |
title_short | Gaining insights into chronic obstructive pulmonary disease exacerbation through emerging biomarkers and the chronic obstructive pulmonary disease assessment test score |
title_sort | gaining insights into chronic obstructive pulmonary disease exacerbation through emerging biomarkers and the chronic obstructive pulmonary disease assessment test score |
topic | COPD exacerbation biomarkers COPD assessment test CAT correlation |
url | https://www.monaldi-archives.org/macd/article/view/2955 |
work_keys_str_mv | AT meghahegde gaininginsightsintochronicobstructivepulmonarydiseaseexacerbationthroughemergingbiomarkersandthechronicobstructivepulmonarydiseaseassessmenttestscore AT sauravraj gaininginsightsintochronicobstructivepulmonarydiseaseexacerbationthroughemergingbiomarkersandthechronicobstructivepulmonarydiseaseassessmenttestscore AT aishwaryaspattanshetti gaininginsightsintochronicobstructivepulmonarydiseaseexacerbationthroughemergingbiomarkersandthechronicobstructivepulmonarydiseaseassessmenttestscore AT sanatkumarbharamunyamagoud gaininginsightsintochronicobstructivepulmonarydiseaseexacerbationthroughemergingbiomarkersandthechronicobstructivepulmonarydiseaseassessmenttestscore |